{"id":1021977,"date":"2026-11-17T17:07:42","date_gmt":"2026-11-17T22:07:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/"},"modified":"2026-11-17T17:07:42","modified_gmt":"2026-11-17T22:07:42","slug":"hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/","title":{"rendered":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position:inside }\n.bwalignl { text-align: left }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection<\/b><\/p>\n<p class=\"bwalignc\"><i>Recognition is part of the Digital Health Hub Foundation Digital Health &amp; AI Awards, which received more than 1,300 submissions globally<\/i><\/p>\n<p>AUSTIN, Texas&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer, Screening &amp; Early Detection category at the Digital Health Hub Foundation Digital Health &amp; AI Awards. The recognition highlights the impact of Natera\u2019s Signatera\u2122 molecular residual disease (MRD) test on cancer care.<\/p>\n<p>The winners were announced live at the 2026 HLTH Conference in Las Vegas. This year\u2019s competition drew more than 1,300 submissions worldwide, recognizing innovations advancing healthcare across multiple categories. The Cancer, Screening &amp; Early Detection category was introduced for the first time this year, reflecting the growing role of digital and data-driven tools in the cancer continuum.<\/p>\n<p>Signatera is a personalized MRD and monitoring test for patients diagnosed with cancer, designed to the unique genomic signature of each patient\u2019s tumor. Signatera detects and quantifies tiny fragments of circulating tumor DNA (ctDNA) in the blood, providing an early signal of disease recurrence and therapy response across cancer types. It is the most widely adopted and extensively validated MRD test, used by the majority of oncologists in the U.S.<\/p>\n<p>\u201cSignatera is transforming the practice of medicine by enabling earlier, more targeted interventions for those patients who need them, and by helping spare others from unnecessary treatment and its side effects,\u201d said Solomon Moshkevich, Chief Executive Officer, Natera. \u201cWe are honored by this recognition from HLTH 2026, and we are grateful to the patients, clinicians, researchers, and partners who make our work possible.\u201d<\/p>\n<p><strong>About Natera<\/strong><\/p>\n<p>Natera is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women\u2019s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera\u2019s tests are supported by more than 475 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, San Carlos, California, and Boulder, Colorado. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.natera.com%2F&amp;esheet=54642771&amp;newsitemid=20261117966880&amp;lan=en-US&amp;anchor=www.natera.com&amp;index=1&amp;md5=a6a7c95ed07ad3873adba4a15499237a\">www.natera.com<\/a>.<\/p>\n<p><strong>Forward-Looking Statements<\/strong><\/p>\n<p>All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera\u2019s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera\u2019s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in &#8220;Risk Factors&#8221; in Natera\u2019s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.natera.com%2Foverview%2Fdefault.aspx&amp;esheet=54642771&amp;newsitemid=20261117966880&amp;lan=en-US&amp;anchor=www.natera.com%2Finvestors&amp;index=2&amp;md5=b9423ea6285da8e2c92f77324295d1dc\">www.natera.com\/investors<\/a> and <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov%2F&amp;esheet=54642771&amp;newsitemid=20261117966880&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=3&amp;md5=6bedf08203bf1a928370010711b5429d\">www.sec.gov<\/a>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20261117966880\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20261117966880\/en\/<\/a><\/span><\/p>\n<p class=\"bwalignl\">Investor Relations: Mike Brophy, CFO, Natera, Inc., <a rel=\"nofollow\" href=\"mailto:investor@natera.com\">investor@natera.com<\/a><br \/>Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., <a rel=\"nofollow\" href=\"mailto:pr@natera.com\">pr@natera.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Texas Nevada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Technology Genetics Health Technology Biotechnology Health General Health Data Management Artificial Intelligence Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20261117966880\/en\/1736351\/3\/Natera_floret_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection Recognition is part of the Digital Health Hub Foundation Digital Health &amp; AI Awards, which received more than 1,300 submissions globally AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer, Screening &amp; Early Detection category at the Digital Health Hub Foundation Digital Health &amp; AI Awards. The recognition highlights the impact of Natera\u2019s Signatera\u2122 molecular residual disease (MRD) test on cancer care. The winners were announced live at the 2026 HLTH Conference in Las Vegas. This year\u2019s competition drew more than 1,300 submissions worldwide, recognizing innovations advancing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1021977","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection Recognition is part of the Digital Health Hub Foundation Digital Health &amp; AI Awards, which received more than 1,300 submissions globally AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer, Screening &amp; Early Detection category at the Digital Health Hub Foundation Digital Health &amp; AI Awards. The recognition highlights the impact of Natera\u2019s Signatera\u2122 molecular residual disease (MRD) test on cancer care. The winners were announced live at the 2026 HLTH Conference in Las Vegas. This year\u2019s competition drew more than 1,300 submissions worldwide, recognizing innovations advancing &hellip; Continue reading &quot;HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-17T22:07:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection\",\"datePublished\":\"2026-11-17T22:07:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/\"},\"wordCount\":640,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/\",\"name\":\"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-11-17T22:07:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/","og_locale":"en_US","og_type":"article","og_title":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk","og_description":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection Recognition is part of the Digital Health Hub Foundation Digital Health &amp; AI Awards, which received more than 1,300 submissions globally AUSTIN, Texas&#8211;(BUSINESS WIRE)&#8211;Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named the Best in Class winner in the Cancer, Screening &amp; Early Detection category at the Digital Health Hub Foundation Digital Health &amp; AI Awards. The recognition highlights the impact of Natera\u2019s Signatera\u2122 molecular residual disease (MRD) test on cancer care. The winners were announced live at the 2026 HLTH Conference in Las Vegas. This year\u2019s competition drew more than 1,300 submissions worldwide, recognizing innovations advancing &hellip; Continue reading \"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-17T22:07:42+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection","datePublished":"2026-11-17T22:07:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/"},"wordCount":640,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/","name":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-11-17T22:07:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20261117966880r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hlth-2026-names-natera-best-in-class-winner-in-cancer-screening-early-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HLTH 2026 Names Natera Best-in-Class Winner in Cancer, Screening &amp; Early Detection"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1021977"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1021977\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1021977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1021977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1021977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}